Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Cancer|October 16, 2018
Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential valueJuliana E Hidalgo-Lόpez, Rashmi Kanagal-Shamanna, Andrés E Quesada, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 5, 2017
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphomaAndrés E Quesada, L Jeffrey Medeiros, Parth A Desai, et al.
Hemasphere|October 24, 2025
A Phase 2 study of CPX-351 in combination with venetoclax in patients with newly diagnosed high-risk acute myeloid leukemiaWei-Ying Jen, Jennifer Croden, Emmanuel Almanza-Huante, et al.
Iscience|January 15, 2026
Integrative spatial multi-omics reveal niche-specific inflammatory signaling and differentiation hierarchies in AMLEnes Dasdemir, Ivo Veletic, Christopher P Ly, et al.
Cancers|November 13, 2021
CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and ManagementRichard K Yang, Gokce A Toruner, Wei Wang, et al.
American Journal of Hematology|July 17, 2024
Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemiaSanam Loghavi, Qing Wei, Farhad Ravandi, et al.
Cancers|November 13, 2025
Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute LeukemiaChi Young Ok, Guilin Tang, Sanam Loghavi, et al.
Blood Cancer Discovery|April 14, 2026
Integrated analysis of genomics, molecular responses and outcomes of CBF-AML with FLAG based therapy on a phase 2 trialJayastu Senapati, Hagop M Kantarjian, Edward Ayoub, et al.
Cancer|June 19, 2024
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentageGeorgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Pageof 11